Form 4: Medtronic CAO Denise Blomquist Reports Share Withholding

Medtronic Chief Accounting Officer Denise L. Blomquist reported the withholding of 237 ordinary shares to cover tax obligations related to vested restricted stock units.

Summary

• Denise L. Blomquist, Chief Accounting Officer of Medtronic plc, executed a transaction on June 5, 2026.
• The transaction involved the withholding of 237 ordinary shares by the company.
• The shares were withheld at a price of $83.32 per share.
• The withholding was conducted to satisfy tax obligations resulting from the vesting of performance-based restricted stock units on April 24, 2026.
• Following this transaction, the reporting person maintains direct beneficial ownership of 14,737 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative tax settlement rather than a discretionary market trade.

Positives

• The transaction reflects the settlement of previously granted performance-vesting restricted stock units, indicating alignment with long-term incentive compensation structures.

Negatives

• None identified; this is a routine administrative transaction related to tax withholding.

Risks

• None identified; this is a standard regulatory disclosure of a non-discretionary tax withholding event.

Future Outlook

Not applicable; this filing is a retrospective report of a completed transaction.

Industry Context

StockSavvy.ai notes that routine tax withholding filings by corporate officers are standard administrative procedures and do not typically signal changes in management sentiment or strategic direction.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for equity-based compensation settlement in large-cap medical device companies.
• The use of 'sell-to-cover' or share withholding for tax obligations is a common industry practice among S&P 500 executives.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard tax-related equity settlement.

Next Steps

• No further actions required by the reporting person regarding this specific transaction.

Key Dates

Keywords

Medtronic, MDT, Form 4, Insider Trading, Chief Accounting Officer, Equity Compensation